N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats.
D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D016207:Cytokines / Q000097:blood / Q000187:drug effects; D004336:Drug Antagonism; D016166:Free Radical Scavengers / Q000494:pharmacology*; D007375:Interleukin-1 / Q000097:blood; D008070:Lipopolysaccharides / Q000009:adverse effects*; D008297:Male; D008760:Methylguanidine / Q000097:blood; D009102:Multiple Organ Failure / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D009569:Nitric Oxide / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D012772:Shock, Septic / Q000097:blood / Q000150:complications / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D016207:Cytokines; D016166:Free Radical Scavengers; D007375:Interleukin-1; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D008760:Methylguanidine; D000111:Acetylcysteine